Issue of Equity and Total Voting Rights

RNS Number : 8666R
Litigation Capital Management Ltd
10 March 2021
 

10 March 2021

 

Litigation Capital Management Limited

("LCM" or the "Company")

 

Issue of Equity and Total Voting Rights

 

Litigation Capital Management Limited (AIM:LIT), a leading international provider of litigation financing solutions, announces that that it has allotted and issued 433,258 ordinary shares in the Company pursuant to the conversion of nil paid shares.  

 

The Company has made an application for the 433,258 Ordinary Shares to be admitted to trading on AIM ("Admission"). Admission is expected to become effective at 8.00 a.m. on 17 March 2021. Following Admission, the Company will have 116,087,924 Ordinary Shares in issue, each with voting rights, which figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules. The Company does not hold any Ordinary Shares in Treasury.

 

- ENDS -

 

Enquiries

 

Litigation Capital Management

c/o Alma PR 

Patrick Moloney, Chief Executive Officer

 

 

 

 

 

Canaccord (Nomad and Joint Broker) 

Tel: 020 7523 8000

Bobbie Hilliam

 

 

 

 

 

Investec Bank plc (Joint Broker)

Tel: 020 7597 5970

David Anderson

 

 

 

 

 

Alma PR

Tel: 020 3405 0205

Justine James

Susie Hudson

LCM@almapr.co.uk

Kieran Breheny

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAPDEFELFEFA
UK 100

Latest directors dealings